EP Patent

EP0523845A3 — New benzodiazepine analogs

Assigned to Merck and Co Inc · Expires 1993-11-18 · 32y expired

What this patent protects

Patent listed against remimazolam-besylate.

Drugs covered by this patent

remimazolam-besylate (REMIMAZOLAM BESYLATE)

Patent Metadata

Patent number: EP0523845A3
Jurisdiction: EP
Classification: —
Expires: 1993-11-18
Drug substance claim: No
Drug product claim: No
Assignee: Merck and Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.